Departing FDA Head Gottlieb Advises Successor Sharpless To Heed Center Directors, Defends Budget To Congress
In addition to sharing parting advice he gave to incoming acting US FDA Commissioner Ned Sharpless on leading the agency, current FDA chief Scott Gottlieb told the House Appropriations Committee’s Agriculture, Rural Development and FDA Subcommittee on April 3 that the proposed fiscal year 2020 budget would support a new “knowledge management system” at the agency to make reviews of device product applications more efficient.
You may also be interested in...
Addressing for the last time the House Appropriations subcommittee with FDA oversight, Commissioner Scott Gottlieb shared his vision for sharpening cosmetics oversight in the absence of significant new resources.
After a week of speculation as to who will succeed US FDA Commissioner Scott Gottlieb when he steps down next month, Health and Human Services Secretary Alex Azar announced during a congressional hearing that National Cancer Institute Director Ned Sharpless will step in as acting commissioner. One note of medtech interest in Sharpless' bio: he was a co-founder of a diagnostics company.
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.